The Clorox Co (CLX), The Procter & Gamble Company (PG): An Undervalued Industry Giant

The search for undervalued companies has yielded many results after the recent downturn in the market. However, none stick out more than The Clorox Co (NYSE:CLX). This international titan has fallen over 6.5% from its 52-week high, and is poised for a large run from its current level.

The Clorox Co (NYSE:CLX)

The company

The Clorox Co (NYSE:CLX) is a worldwide leader in the manufacturing and marketing of consumer products. It is home to some of the most popular brands that many consumers use every single day. In fact, 90% of The Clorox Co (NYSE:CLX)’s brands hold the number one or number two ranking in its market:

Brand Market Share Ranking
Clorox Disinfecting Wipes 45% #1
Clorox Toilet Bowl Cleaner 35% #1
Pine-Sol 30% #1
Tilex / Clorox Bath Cleaner 21% #1
Kingsford / Match Light 72% #1
Brita Water Filtration 68% #1
Clorox Bleach 64% #1
Burt’s Bees 20% #1
Liquid-Plumr 37% #2
Clorox Clean-Up Spray 14% #2
Clorox 2 for Colors 26% #2
Fresh Step / Scoop Away 27% #2
Glad Disposal & Food Storage 19% #2
Hidden Valley Salad Dressing 17% #2

Fourth quarter results

On Aug. 1, The Clorox Co (NYSE:CLX) released its fourth quarter report for fiscal 2013. The results were mixed, but positive overall.

  • Earnings per share of $1.38 vs. expectations of $1.34
  • Revenues of $1.5 billion vs. expectations of $1.6 billion
Earnings per share increased 5% and revenue rose 0.4% year-over-year. Gross margin for the quarter expanded 130 basis points to 44%, thanks to cost savings and price increases. Even with the increased revenue, volume in several segments saw a decline from the same period in 2012. However, the strength of The Clorox Co (NYSE:CLX)’s brands will help boost volume back to normal levels, and this could push sales to record highs.

Fiscal 2013 results

Statistic 2012 2013 Year-Over-Year Growth
Earnings Per Share $4.10 $4.31 5.12%
Revenues $5.468 billion $5.623 billion 2.84%
Gross Margin 42.1% 42.9% 80 basis points

Financial results for fiscal 2013 were in-line with analyst expectations. The most notable statistic in the report is the increase in gross margin. By making more profit on its products, The Clorox Co (NYSE:CLX)’s volume could remain flat and still see its revenue rise. Gross margin could easily surpass the 43.5% mark for fiscal 2014.

Outlook

In the fourth quarter report, Clorox confirmed its outlook for fiscal 2014. The expectations currently call for:

  • 2%-4% sales growth
  • Earnings per share of $4.55 to $4.70
  • Increased cost savings
  • Lower selling and administrative costs
This outlook is in line with the consensus analyst expectations of $4.62 earnings per share on $5.8 billion in revenue. Also, it is safe to assume that 2014 will be the 38th consecutive year with a dividend raise. Increased sales, increased cost savings, and reduced expenses create a recipe for great success.

Free cash flow 

Clorox reported $583 million in free cash flow for 2013, a 36% increase from 2012. This free cash flow is often used to increase distributions to shareholders, as it has raised its dividend every year since 1977. There is no reason for this streak to end anytime soon.

Free cash flow has also been used by management to initiate share repurchases. Share repurchases reduce the amount of shares outstanding, which boosts earnings per share and makes the remaining shares more valuable. In the fourth quarter, Clorox repurchased about 1.5 million shares for approximately $128 million. Management says its number one priority is creating stockholder value, and their actions confirm this to be the truth.

Competitive industry

The household products industry provides plenty of competition for Clorox. The Procter & Gamble Company (NYSE:PG) and Kimberly Clark Corp (NYSE:KMB are two of the largest companies in the world. The Procter & Gamble Company (NYSE:PG) is most known for its brands such as Tide, Duracell, Vicks, Mr. Clean, Pampers, and Febreze. Kimberly Clark Corp (NYSE:KMB)’s brand portfolio includes Kleenex, Cottonelle, Huggies, Scott, and Kotex. All of these include products we currently use or have used in the past, much like Clorox’s line.

Company Clorox Proctor & Gamble Kimberly-Clark
Market Cap  $11.1 billion  $219 billion  $36.8 billion
P/E  19.5  20.7  20.4
Forward P/E  17.1  17.1  15.85
Dividend Yield  3.4%  3%  3.4%
YTD Performance  +13.2%  +15%  +10.7%

(Source: Yahoo! Finance)

All three of the companies in focus have incredible brand strength and market share. In the analysis, Clorox is shown to be trading at the cheapest valuation today, but all have favorable growth going forward and have performed well year-to-date. Through innovation, they each have the ability to continue to grow for decades and would make for good investments. However, Clorox’s low market cap gives it a much higher potential to double or become the next big takeover target. For years, Clorox has been said to be the perfect fit for Warren Buffett’s Berkshire Hathaway portfolio, and I could not agree more. Buying a stock based on the possibility for a takeover is not always a smart move, but when it comes to a fundamentally strong company that will do well regardless, it is very smart.

The bottom line

Clorox is one of the most undervalued companies in the market today. It is expected grow consistently over the next several years, and its healthy 3.4% dividend will provide additional returns. Keep an eye on this one and take a look to see if it would fit your investment strategy.

The article An Undervalued Industry Giant originally appeared on Fool.com and is written by Joseph Solitro.

Joseph Solitro has a long position in Clorox. The Motley Fool recommends Kimberly-Clark and Procter & Gamble (NYSE:PG). 

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.